157 related articles for article (PubMed ID: 10818326)
21. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
[TBL] [Abstract][Full Text] [Related]
22. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
23. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
Mezin P; Payen JF; Bosson JL; Brambilla E; Stieglitz P
Br J Anaesth; 1997 Sep; 79(3):327-31. PubMed ID: 9389850
[TBL] [Abstract][Full Text] [Related]
24. Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals.
Johannsen S; Roewer N; Schuster F
Anesth Analg; 2012 Oct; 115(4):925-8. PubMed ID: 22696611
[TBL] [Abstract][Full Text] [Related]
25. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
[TBL] [Abstract][Full Text] [Related]
26. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J
Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
[TBL] [Abstract][Full Text] [Related]
27. High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man.
Wappler F; Roewer N; Lenzen C; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
Br J Anaesth; 1994 Feb; 72(2):240-2. PubMed ID: 8110584
[TBL] [Abstract][Full Text] [Related]
28. Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands.
Islander G; Bendixen D; Ranklev-Twetman E; Ording H
Acta Anaesthesiol Scand; 1996 May; 40(5):579-84. PubMed ID: 8792888
[TBL] [Abstract][Full Text] [Related]
29. In vitro effects of levosimendan on muscle of malignant hyperthermia susceptible and non-susceptible swine.
Schuster F; Johannsen S; Isbary S; Türkmeneli I; Roewer N
BMC Anesthesiol; 2018 Dec; 18(1):182. PubMed ID: 30509180
[TBL] [Abstract][Full Text] [Related]
30. [Ryanodine-induced contractures for the diagnosis of malignant hyperthermia susceptibility].
Lenzen C; Roewer N; Scholz J; Rumberger E; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):459-63. PubMed ID: 1786306
[TBL] [Abstract][Full Text] [Related]
31. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
[TBL] [Abstract][Full Text] [Related]
32. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J
J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
[TBL] [Abstract][Full Text] [Related]
33. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].
Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Matschke J; Winkler G; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):373-80. PubMed ID: 9689395
[TBL] [Abstract][Full Text] [Related]
34. Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia.
Vellecco V; Mancini A; Ianaro A; Calderone V; Attanasio C; Cantalupo A; Andria B; Savoia G; Panza E; Di Martino A; Cirino G; Bucci M
Clin Sci (Lond); 2016 Jan; 130(1):35-44. PubMed ID: 26460077
[TBL] [Abstract][Full Text] [Related]
35. Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.
von Breunig F; Wappler F; Hagel C; von Richthofen V; Fiege M; Weisshorn R; Stavrou D; Schulte am Esch J
Anesthesiology; 2004 Apr; 100(4):789-94. PubMed ID: 15087612
[TBL] [Abstract][Full Text] [Related]
36. Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodine.
Martens U; Krause T; Scholz J; Wappler F; Steinrücke K; am Esch JS
Eur J Anaesthesiol; 2000 Jun; 17(6):364-72. PubMed ID: 10928436
[TBL] [Abstract][Full Text] [Related]
37. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
Sudo RT; Nelson TE
J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
[TBL] [Abstract][Full Text] [Related]
38. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
Snoeck MM; Gielen MJ; Tangerman A; van Egmond J; Dirksen R
Acta Anaesthesiol Scand; 2000 Mar; 44(3):334-7. PubMed ID: 10714850
[TBL] [Abstract][Full Text] [Related]
39. Effects of theophylline on anesthetized malignant hyperthermia-susceptible pigs.
Fiege M; Weisshorn R; Kolodzie K; Wappler F; Gerbershagen MU
J Biomed Biotechnol; 2011; 2011():937479. PubMed ID: 22131820
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
